Connect with us

Announcements

CannTrust Q2 Filing Deadline and Insider Trading Blackout Announcement

Published

on

CannTrust Q2 Filing Deadline and Insider Trading Blackout Announcement

It is reported that Canadian company CannTrust has been conducting unlicensed growing, and that executives knew about it.

CannTrust also recently announced in a press release on August 1, 2019, that it anticipates late filing financial statements and a proposed management cease trade order. According to the press release, the deadline to file interim financial reports is August 14, 2019 for three and six month periods that ended on July 30, 2019. The press release suggests that the delay may be due to the “significant uncertainty with respect to the potential impact of pending Health Canada decisions on the valuation of the Company's inventory and biological assets and revenue recognition.”

Additionally, the press release also indicates that CannaTrust previously disclosed that it received a compliance report from Health Canada concerning that its Niagara Facility is non-compliant with regulations due to observations made by Health Canada. The investigation resulted in Health Canada placing a hold on “inventory which includes approximately 5,200 kg of dried cannabis that was impacted by the previously unlicensed rooms at the Company’s Niagara Facility.” CannaTrust placed a temporary hold voluntarily at its facility in Vaughn, Ontario, as well.

There also appears to be uncertainty concerning the nature, timing, and potential impact of the Health Canada decision on CannTrust inventory and biological assets. There is no indication as to how Health Canada’s determination will impact the CannTrust financial disclosure in Q2 filings, and the company may also need to restate some of its historical and financial statements concerning management and analysis from December 31, 2018 to March 31, 2019.

CannTrust expresses in the press release that it expects to file Q2 Filings and, if needed, the restated financials, as soon as possible.

The company also placed an informal blackout on directors and management concerning share trading. Greenhill & Co. Canada Ltd. is conducting a strategic review.

CannTrust stated about the hiring,

“That review is in its early stages and is ongoing. Today, staff of the OSC advised the special committee’s legal counsel that an investigation has been opened into matters and parties related to CannTrust and the investigation has been assigned to the Joint Serious Offences Team of the Enforcement Branch of the OSC.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.